Comparative efficacy of Keishi-bukuryo-gan and Pentoxifylline on RBC deformability in patients with “oketsu” syndrome

Keishi-bukuryo-gan (Gui-Zhi-Fu-Ling-Wan) (KBG) is one of the prescriptions in Japanese traditional medicine for improving the “oketsu” syndrome, so-called blood stasis syndrome. “Oketsu” syndrome is an important pathological conception in Japanese traditional medicine and often accompanies cerebro-v...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Phytomedicine (Stuttgart) 2003-01, Vol.10 (6), p.459-466
Hauptverfasser: Hikiami, H., Goto, H., Sekiya, N., Hattori, N., Sakakibara, I., Shimada, Y., Terasawa, K.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 466
container_issue 6
container_start_page 459
container_title Phytomedicine (Stuttgart)
container_volume 10
creator Hikiami, H.
Goto, H.
Sekiya, N.
Hattori, N.
Sakakibara, I.
Shimada, Y.
Terasawa, K.
description Keishi-bukuryo-gan (Gui-Zhi-Fu-Ling-Wan) (KBG) is one of the prescriptions in Japanese traditional medicine for improving the “oketsu” syndrome, so-called blood stasis syndrome. “Oketsu” syndrome is an important pathological conception in Japanese traditional medicine and often accompanies cerebro-vascular disorders. Previously, we were able to reveal a deterioration of RBC (Red blood cell) deformability and viscoelasticity in patients with “oketsu” syndrome. The purpose of the present study was to evaluate whether KBG has an effect on RBC deformability in comparison with pentoxifylline (PXF). The subjects were 30 male patients with multiple lacunar infarctions. Eighteen patients (44–79 yrs, mean ±SD, 66.1 ± 10.7 yrs) were treated with 12 g of KBG daily for 4 weeks (KBG group). Twelve patients (59–78 yrs, 70.7 ± 6.4 yrs) were treated with 300 mg of PXF daily for 4 weeks (PXF group). Based on the “oketsu” score, the patients of each group were divided into two subgroups, a non-“oketsu” group (“oketsu” score 20 points or less) and an “oketsu” group (“oketsu” score 21 points or higher). KBG had significant effects on RBC deformability as evaluated by filtration method. KBG also significantly increased intracellular ATP content, as did PXF. Moreover, KBG was more effective for patients with a more severe “oketsu” state. However, PXF was effective only in patients with “oketsu” syndrome, who might have deteriorated RBC deformability. In conclusion, the effect of KBG on RBC deformability was by no means inferior to PXF.
doi_str_mv 10.1078/094471103322331395
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_73653032</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A109026444</galeid><els_id>S0944711304702482</els_id><sourcerecordid>A109026444</sourcerecordid><originalsourceid>FETCH-LOGICAL-c456t-feb6ed5eef287706051aff2413f11c0f646c301beabf9ad343e47c12888d84b93</originalsourceid><addsrcrecordid>eNp90c9qFTEUBvAgir2tvoALCS7cTc2_mcyAm3qxKhYUUXAXMsnJbdqZ5JrMVGfXB9GX65OYci8IWiSLQPh9h0M-hJ5QckyJbF-QTghJKeGcMc4p7-p7aEUb2lakq7_eR6tbUBXBD9BhzheEUNFJ8hAdUN7IlrF2hZZ1HLc66clfAQbnvNFmwdHh9-Dzua_6-XJOS6w2OmAdLP4IYYo_vFuGwQfAMeBPr9bYgotp1L0f_LRgH_C2DCwy4-9-Osc31z_jJUx5vrn-hfMSbIojPEIPnB4yPN7fR-jL6evP67fV2Yc379YnZ5URdTNVDvoGbA3gWCslaUhNtXNMUO4oNcQ1ojGc0B507zptueAgpKGsbVvbir7jR-j5bu42xW8z5EmNPhsYBh0gzllJ3tSccFbgs7_gRZxTKLspRupaECJlQdUObfQAygcXp6TNBgIkPcQAzpfnE0o6whohRPHHd_hyLIze3Blgu4BJMecETm2TH3VaFCXqtnb1b-0l9HS_-tyPYP9E9j0X8HIHoPz0lYeksikFGbA-gZmUjf5_838DXMy8xA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>205540077</pqid></control><display><type>article</type><title>Comparative efficacy of Keishi-bukuryo-gan and Pentoxifylline on RBC deformability in patients with “oketsu” syndrome</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Hikiami, H. ; Goto, H. ; Sekiya, N. ; Hattori, N. ; Sakakibara, I. ; Shimada, Y. ; Terasawa, K.</creator><creatorcontrib>Hikiami, H. ; Goto, H. ; Sekiya, N. ; Hattori, N. ; Sakakibara, I. ; Shimada, Y. ; Terasawa, K.</creatorcontrib><description>Keishi-bukuryo-gan (Gui-Zhi-Fu-Ling-Wan) (KBG) is one of the prescriptions in Japanese traditional medicine for improving the “oketsu” syndrome, so-called blood stasis syndrome. “Oketsu” syndrome is an important pathological conception in Japanese traditional medicine and often accompanies cerebro-vascular disorders. Previously, we were able to reveal a deterioration of RBC (Red blood cell) deformability and viscoelasticity in patients with “oketsu” syndrome. The purpose of the present study was to evaluate whether KBG has an effect on RBC deformability in comparison with pentoxifylline (PXF). The subjects were 30 male patients with multiple lacunar infarctions. Eighteen patients (44–79 yrs, mean ±SD, 66.1 ± 10.7 yrs) were treated with 12 g of KBG daily for 4 weeks (KBG group). Twelve patients (59–78 yrs, 70.7 ± 6.4 yrs) were treated with 300 mg of PXF daily for 4 weeks (PXF group). Based on the “oketsu” score, the patients of each group were divided into two subgroups, a non-“oketsu” group (“oketsu” score 20 points or less) and an “oketsu” group (“oketsu” score 21 points or higher). KBG had significant effects on RBC deformability as evaluated by filtration method. KBG also significantly increased intracellular ATP content, as did PXF. Moreover, KBG was more effective for patients with a more severe “oketsu” state. However, PXF was effective only in patients with “oketsu” syndrome, who might have deteriorated RBC deformability. In conclusion, the effect of KBG on RBC deformability was by no means inferior to PXF.</description><identifier>ISSN: 0944-7113</identifier><identifier>EISSN: 1618-095X</identifier><identifier>DOI: 10.1078/094471103322331395</identifier><identifier>PMID: 13678228</identifier><language>eng</language><publisher>Germany: Elsevier GmbH</publisher><subject>Administration, Oral ; Adult ; Aged ; Blood ; Cerebral Infarction - drug therapy ; Cerebral Infarction - pathology ; Chromatography, High Pressure Liquid ; Drug therapy ; Drugs, Chinese Herbal - administration &amp; dosage ; Drugs, Chinese Herbal - pharmacology ; Drugs, Chinese Herbal - therapeutic use ; Erythrocyte Deformability - drug effects ; Erythrocytes ; Evaluation ; Hemolysis - drug effects ; hemorheology ; Humans ; Japan ; Kampo medicine ; Keishi-bukuryo-gan ; Male ; Medicinal plants ; Medicine, Traditional ; Middle Aged ; Pentoxifylline ; Pentoxifylline - administration &amp; dosage ; Pentoxifylline - pharmacology ; Pentoxifylline - therapeutic use ; Phytotherapy ; Platelet Aggregation Inhibitors - administration &amp; dosage ; Platelet Aggregation Inhibitors - pharmacology ; Platelet Aggregation Inhibitors - therapeutic use ; RBC deformability ; Rheology ; Severity of Illness Index ; Statistics ; Treatment Outcome</subject><ispartof>Phytomedicine (Stuttgart), 2003-01, Vol.10 (6), p.459-466</ispartof><rights>2003 Urban &amp; Fischer Verlag</rights><rights>COPYRIGHT 2003 Urban &amp; Fischer Verlag</rights><rights>Copyright Urban &amp; Fischer Verlag 2003</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c456t-feb6ed5eef287706051aff2413f11c0f646c301beabf9ad343e47c12888d84b93</citedby><cites>FETCH-LOGICAL-c456t-feb6ed5eef287706051aff2413f11c0f646c301beabf9ad343e47c12888d84b93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0944711304702482$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/13678228$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hikiami, H.</creatorcontrib><creatorcontrib>Goto, H.</creatorcontrib><creatorcontrib>Sekiya, N.</creatorcontrib><creatorcontrib>Hattori, N.</creatorcontrib><creatorcontrib>Sakakibara, I.</creatorcontrib><creatorcontrib>Shimada, Y.</creatorcontrib><creatorcontrib>Terasawa, K.</creatorcontrib><title>Comparative efficacy of Keishi-bukuryo-gan and Pentoxifylline on RBC deformability in patients with “oketsu” syndrome</title><title>Phytomedicine (Stuttgart)</title><addtitle>Phytomedicine</addtitle><description>Keishi-bukuryo-gan (Gui-Zhi-Fu-Ling-Wan) (KBG) is one of the prescriptions in Japanese traditional medicine for improving the “oketsu” syndrome, so-called blood stasis syndrome. “Oketsu” syndrome is an important pathological conception in Japanese traditional medicine and often accompanies cerebro-vascular disorders. Previously, we were able to reveal a deterioration of RBC (Red blood cell) deformability and viscoelasticity in patients with “oketsu” syndrome. The purpose of the present study was to evaluate whether KBG has an effect on RBC deformability in comparison with pentoxifylline (PXF). The subjects were 30 male patients with multiple lacunar infarctions. Eighteen patients (44–79 yrs, mean ±SD, 66.1 ± 10.7 yrs) were treated with 12 g of KBG daily for 4 weeks (KBG group). Twelve patients (59–78 yrs, 70.7 ± 6.4 yrs) were treated with 300 mg of PXF daily for 4 weeks (PXF group). Based on the “oketsu” score, the patients of each group were divided into two subgroups, a non-“oketsu” group (“oketsu” score 20 points or less) and an “oketsu” group (“oketsu” score 21 points or higher). KBG had significant effects on RBC deformability as evaluated by filtration method. KBG also significantly increased intracellular ATP content, as did PXF. Moreover, KBG was more effective for patients with a more severe “oketsu” state. However, PXF was effective only in patients with “oketsu” syndrome, who might have deteriorated RBC deformability. In conclusion, the effect of KBG on RBC deformability was by no means inferior to PXF.</description><subject>Administration, Oral</subject><subject>Adult</subject><subject>Aged</subject><subject>Blood</subject><subject>Cerebral Infarction - drug therapy</subject><subject>Cerebral Infarction - pathology</subject><subject>Chromatography, High Pressure Liquid</subject><subject>Drug therapy</subject><subject>Drugs, Chinese Herbal - administration &amp; dosage</subject><subject>Drugs, Chinese Herbal - pharmacology</subject><subject>Drugs, Chinese Herbal - therapeutic use</subject><subject>Erythrocyte Deformability - drug effects</subject><subject>Erythrocytes</subject><subject>Evaluation</subject><subject>Hemolysis - drug effects</subject><subject>hemorheology</subject><subject>Humans</subject><subject>Japan</subject><subject>Kampo medicine</subject><subject>Keishi-bukuryo-gan</subject><subject>Male</subject><subject>Medicinal plants</subject><subject>Medicine, Traditional</subject><subject>Middle Aged</subject><subject>Pentoxifylline</subject><subject>Pentoxifylline - administration &amp; dosage</subject><subject>Pentoxifylline - pharmacology</subject><subject>Pentoxifylline - therapeutic use</subject><subject>Phytotherapy</subject><subject>Platelet Aggregation Inhibitors - administration &amp; dosage</subject><subject>Platelet Aggregation Inhibitors - pharmacology</subject><subject>Platelet Aggregation Inhibitors - therapeutic use</subject><subject>RBC deformability</subject><subject>Rheology</subject><subject>Severity of Illness Index</subject><subject>Statistics</subject><subject>Treatment Outcome</subject><issn>0944-7113</issn><issn>1618-095X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp90c9qFTEUBvAgir2tvoALCS7cTc2_mcyAm3qxKhYUUXAXMsnJbdqZ5JrMVGfXB9GX65OYci8IWiSLQPh9h0M-hJ5QckyJbF-QTghJKeGcMc4p7-p7aEUb2lakq7_eR6tbUBXBD9BhzheEUNFJ8hAdUN7IlrF2hZZ1HLc66clfAQbnvNFmwdHh9-Dzua_6-XJOS6w2OmAdLP4IYYo_vFuGwQfAMeBPr9bYgotp1L0f_LRgH_C2DCwy4-9-Osc31z_jJUx5vrn-hfMSbIojPEIPnB4yPN7fR-jL6evP67fV2Yc379YnZ5URdTNVDvoGbA3gWCslaUhNtXNMUO4oNcQ1ojGc0B507zptueAgpKGsbVvbir7jR-j5bu42xW8z5EmNPhsYBh0gzllJ3tSccFbgs7_gRZxTKLspRupaECJlQdUObfQAygcXp6TNBgIkPcQAzpfnE0o6whohRPHHd_hyLIze3Blgu4BJMecETm2TH3VaFCXqtnb1b-0l9HS_-tyPYP9E9j0X8HIHoPz0lYeksikFGbA-gZmUjf5_838DXMy8xA</recordid><startdate>20030101</startdate><enddate>20030101</enddate><creator>Hikiami, H.</creator><creator>Goto, H.</creator><creator>Sekiya, N.</creator><creator>Hattori, N.</creator><creator>Sakakibara, I.</creator><creator>Shimada, Y.</creator><creator>Terasawa, K.</creator><general>Elsevier GmbH</general><general>Urban &amp; Fischer Verlag</general><general>Elsevier Science Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope></search><sort><creationdate>20030101</creationdate><title>Comparative efficacy of Keishi-bukuryo-gan and Pentoxifylline on RBC deformability in patients with “oketsu” syndrome</title><author>Hikiami, H. ; Goto, H. ; Sekiya, N. ; Hattori, N. ; Sakakibara, I. ; Shimada, Y. ; Terasawa, K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c456t-feb6ed5eef287706051aff2413f11c0f646c301beabf9ad343e47c12888d84b93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Administration, Oral</topic><topic>Adult</topic><topic>Aged</topic><topic>Blood</topic><topic>Cerebral Infarction - drug therapy</topic><topic>Cerebral Infarction - pathology</topic><topic>Chromatography, High Pressure Liquid</topic><topic>Drug therapy</topic><topic>Drugs, Chinese Herbal - administration &amp; dosage</topic><topic>Drugs, Chinese Herbal - pharmacology</topic><topic>Drugs, Chinese Herbal - therapeutic use</topic><topic>Erythrocyte Deformability - drug effects</topic><topic>Erythrocytes</topic><topic>Evaluation</topic><topic>Hemolysis - drug effects</topic><topic>hemorheology</topic><topic>Humans</topic><topic>Japan</topic><topic>Kampo medicine</topic><topic>Keishi-bukuryo-gan</topic><topic>Male</topic><topic>Medicinal plants</topic><topic>Medicine, Traditional</topic><topic>Middle Aged</topic><topic>Pentoxifylline</topic><topic>Pentoxifylline - administration &amp; dosage</topic><topic>Pentoxifylline - pharmacology</topic><topic>Pentoxifylline - therapeutic use</topic><topic>Phytotherapy</topic><topic>Platelet Aggregation Inhibitors - administration &amp; dosage</topic><topic>Platelet Aggregation Inhibitors - pharmacology</topic><topic>Platelet Aggregation Inhibitors - therapeutic use</topic><topic>RBC deformability</topic><topic>Rheology</topic><topic>Severity of Illness Index</topic><topic>Statistics</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hikiami, H.</creatorcontrib><creatorcontrib>Goto, H.</creatorcontrib><creatorcontrib>Sekiya, N.</creatorcontrib><creatorcontrib>Hattori, N.</creatorcontrib><creatorcontrib>Sakakibara, I.</creatorcontrib><creatorcontrib>Shimada, Y.</creatorcontrib><creatorcontrib>Terasawa, K.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Agricultural Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>Phytomedicine (Stuttgart)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hikiami, H.</au><au>Goto, H.</au><au>Sekiya, N.</au><au>Hattori, N.</au><au>Sakakibara, I.</au><au>Shimada, Y.</au><au>Terasawa, K.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparative efficacy of Keishi-bukuryo-gan and Pentoxifylline on RBC deformability in patients with “oketsu” syndrome</atitle><jtitle>Phytomedicine (Stuttgart)</jtitle><addtitle>Phytomedicine</addtitle><date>2003-01-01</date><risdate>2003</risdate><volume>10</volume><issue>6</issue><spage>459</spage><epage>466</epage><pages>459-466</pages><issn>0944-7113</issn><eissn>1618-095X</eissn><abstract>Keishi-bukuryo-gan (Gui-Zhi-Fu-Ling-Wan) (KBG) is one of the prescriptions in Japanese traditional medicine for improving the “oketsu” syndrome, so-called blood stasis syndrome. “Oketsu” syndrome is an important pathological conception in Japanese traditional medicine and often accompanies cerebro-vascular disorders. Previously, we were able to reveal a deterioration of RBC (Red blood cell) deformability and viscoelasticity in patients with “oketsu” syndrome. The purpose of the present study was to evaluate whether KBG has an effect on RBC deformability in comparison with pentoxifylline (PXF). The subjects were 30 male patients with multiple lacunar infarctions. Eighteen patients (44–79 yrs, mean ±SD, 66.1 ± 10.7 yrs) were treated with 12 g of KBG daily for 4 weeks (KBG group). Twelve patients (59–78 yrs, 70.7 ± 6.4 yrs) were treated with 300 mg of PXF daily for 4 weeks (PXF group). Based on the “oketsu” score, the patients of each group were divided into two subgroups, a non-“oketsu” group (“oketsu” score 20 points or less) and an “oketsu” group (“oketsu” score 21 points or higher). KBG had significant effects on RBC deformability as evaluated by filtration method. KBG also significantly increased intracellular ATP content, as did PXF. Moreover, KBG was more effective for patients with a more severe “oketsu” state. However, PXF was effective only in patients with “oketsu” syndrome, who might have deteriorated RBC deformability. In conclusion, the effect of KBG on RBC deformability was by no means inferior to PXF.</abstract><cop>Germany</cop><pub>Elsevier GmbH</pub><pmid>13678228</pmid><doi>10.1078/094471103322331395</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0944-7113
ispartof Phytomedicine (Stuttgart), 2003-01, Vol.10 (6), p.459-466
issn 0944-7113
1618-095X
language eng
recordid cdi_proquest_miscellaneous_73653032
source MEDLINE; Elsevier ScienceDirect Journals
subjects Administration, Oral
Adult
Aged
Blood
Cerebral Infarction - drug therapy
Cerebral Infarction - pathology
Chromatography, High Pressure Liquid
Drug therapy
Drugs, Chinese Herbal - administration & dosage
Drugs, Chinese Herbal - pharmacology
Drugs, Chinese Herbal - therapeutic use
Erythrocyte Deformability - drug effects
Erythrocytes
Evaluation
Hemolysis - drug effects
hemorheology
Humans
Japan
Kampo medicine
Keishi-bukuryo-gan
Male
Medicinal plants
Medicine, Traditional
Middle Aged
Pentoxifylline
Pentoxifylline - administration & dosage
Pentoxifylline - pharmacology
Pentoxifylline - therapeutic use
Phytotherapy
Platelet Aggregation Inhibitors - administration & dosage
Platelet Aggregation Inhibitors - pharmacology
Platelet Aggregation Inhibitors - therapeutic use
RBC deformability
Rheology
Severity of Illness Index
Statistics
Treatment Outcome
title Comparative efficacy of Keishi-bukuryo-gan and Pentoxifylline on RBC deformability in patients with “oketsu” syndrome
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-15T06%3A42%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparative%20efficacy%20of%20Keishi-bukuryo-gan%20and%20Pentoxifylline%20on%20RBC%20deformability%20in%20patients%20with%20%E2%80%9Coketsu%E2%80%9D%20syndrome&rft.jtitle=Phytomedicine%20(Stuttgart)&rft.au=Hikiami,%20H.&rft.date=2003-01-01&rft.volume=10&rft.issue=6&rft.spage=459&rft.epage=466&rft.pages=459-466&rft.issn=0944-7113&rft.eissn=1618-095X&rft_id=info:doi/10.1078/094471103322331395&rft_dat=%3Cgale_proqu%3EA109026444%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=205540077&rft_id=info:pmid/13678228&rft_galeid=A109026444&rft_els_id=S0944711304702482&rfr_iscdi=true